MIVI-TRUST Outcomes Strengthen Support Of Ocriplasmin For Vitreomacular Adhesion | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Tuesday, August 23, 2011

Ocular Surgery News

Ocriplasmin may become the first pharmacologic option for patients with vitreomacular adhesion, according to two presentations here.

Retina Products and Equipment »

All of the following are risk factors for the disorder shown EXCEPT:
1. iris color
2. obesity
3. smoking
4. hypertension
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us